{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Enhancing anti-HIV efficiency through multivalent inhibitors targeting oligomeric gp120", "item": "https://www.patentleaderboard.com/patent/7604804"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Enhancing anti-HIV efficiency through multivalent inhibitors targeting oligomeric gp120

Enhancing anti-HIV efficiency through multivalent inhibitors targeting oligomeric gp120

US Patent 7604804 · Granted Oct 20, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fc glycan remodeling platform method for site-specific antibody conjugation and 2024
Crystalline form of (s)-7-(1-acryloylpiperidin-4-yl)- 2-(4-phenoxyphenyl)-4,5,6,2024
Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,72024
Endo-S2 mutants as glycosynthases, method of making and use for glycoengineering2023
Treatment of B cell cancers using a combination comprising Btk inhibitors2023
Chemoenzymatic glycoengineering of antibodies and Fc fragments thereof2023
Immunotherapy for hepatocellular carcinoma2023
Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,72023
Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer2022
Transglycosylation of endo-S and endo-S mutants for antibody glycosylation remod2022
Treatment cancers using a combination comprising PARP inhibitors2021
Designer α 6-fucosidase mutants enable direct core fucosylation of intact N-glyc2021